participant flow for clinicaltrials:NCT01232491 [clinicaltrials_resource:c570c629ad2230207dc1a20d550f61ef]
participant flow [clinicaltrials_vocabulary:participant-flow]
participant flow for clinicaltrials:NCT01232491 [clinicaltrials_resource:c570c629ad2230207dc1a20d550f61ef]
Bio2RDF identifier
c570c629ad2230207dc1a20d550f61ef
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:c570c629ad2230207dc1a20d550f61ef
group [clinicaltrials_vocabulary:group]
period [clinicaltrials_vocabulary:period]
pre assignment details [clinicaltrials_vocabulary:pre-assignment-details]
Subjects continued on their tr ...... fore insulin detemir was used.
recruitment details [clinicaltrials_vocabulary:recruitment-details]
The trial was conducted at 110 ...... United States of America (76).
identifier
clinicaltrials_resource:c570c629ad2230207dc1a20d550f61ef
title
participant flow for clinicaltrials:NCT01232491
@en
type
label
participant flow for clinicalt ...... 0c629ad2230207dc1a20d550f61ef]
@en